Kobayashi Pharmaceutical Co Price Patterns
| KBYPFDelisted Stock | USD 37.43 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Kobayashi Pharmaceutical hype-based prediction, you can estimate the value of Kobayashi Pharmaceutical Co from the perspective of Kobayashi Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kobayashi Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Kobayashi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kobayashi Pharmaceutical after-hype prediction price | USD 37.43 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kobayashi |
Kobayashi Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Kobayashi Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kobayashi Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kobayashi Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kobayashi Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Kobayashi Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kobayashi Pharmaceutical's historical news coverage. Kobayashi Pharmaceutical's after-hype downside and upside margins for the prediction period are 37.43 and 37.43, respectively. We have considered Kobayashi Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kobayashi Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Kobayashi Pharmaceutical is based on 3 months time horizon.
Kobayashi Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Kobayashi Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kobayashi Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kobayashi Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
37.43 | 37.43 | 0.00 |
|
Kobayashi Pharmaceutical Hype Timeline
Kobayashi Pharmaceutical is now traded for 37.43. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kobayashi is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Kobayashi Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 37.43. About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Kobayashi Pharmaceutical was now reported as 2652.56. The company last dividend was issued on the 29th of December 2022. Kobayashi Pharmaceutical had 2:1 split on the 28th of June 2016. Assuming the 90 days horizon the next projected press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.Kobayashi Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Kobayashi Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Kobayashi Pharmaceutical's future price movements. Getting to know how Kobayashi Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kobayashi Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LIOPF | Lion Corporation | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BICEF | Socit BIC SA | 0.00 | 0 per month | 1.67 | 0.04 | 4.38 | (1.77) | 12.53 | |
| BLUMY | Blue Moon Group | 0.00 | 0 per month | 0.00 | (0.12) | 0.00 | (9.57) | 41.94 | |
| PORBF | POLA Orbis Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMYY | Remy Cointreau SA | 0.00 | 0 per month | 1.59 | 0.04 | 4.48 | (3.09) | 10.81 | |
| REMYF | Rmy Cointreau SA | 0.00 | 0 per month | 1.75 | 0.03 | 5.68 | (3.65) | 19.88 | |
| KNKZF | KWS SAAT SE | 0.00 | 0 per month | 0.00 | 0.17 | 2.00 | 0.00 | 8.42 | |
| KSRYY | Kose Corp ADR | 0.00 | 0 per month | 2.49 | (0.01) | 4.90 | (4.67) | 15.46 | |
| MIOFF | Milbon Co | 0.00 | 0 per month | 0.00 | (0.55) | 0.00 | 0.00 | 1.22 | |
| OCDGF | Ocado Group PLC | 0.00 | 0 per month | 3.74 | 0.05 | 11.24 | (7.48) | 36.89 |
Kobayashi Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Kobayashi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kobayashi using various technical indicators. When you analyze Kobayashi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kobayashi Pharmaceutical Predictive Indicators
The successful prediction of Kobayashi Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kobayashi Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kobayashi Pharmaceutical based on analysis of Kobayashi Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kobayashi Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kobayashi Pharmaceutical's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |